Metropolitan Life Insurance Company (MetLife)’s Tectonic Therapeutic TECX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-259	Closed	-$17.4K	–	2838
2021 Q3	$17.4K	Sell	259 -569	-69%	-$46.7K	﹤0.01%	2827
2021 Q2	$88.3K	Buy	828 +98	+13%	+$11.6K	﹤0.01%	2620
2021 Q1	$111K	Sell	730 -98	-12%	-$15.9K	﹤0.01%	2379
2020 Q4	$138K	Hold	828	–	–	﹤0.01%	2184
2020 Q3	$129K	Hold	828	–	–	﹤0.01%	2069
2020 Q2	$173K	Buy	828 +182	+28%	+$37.5K	﹤0.01%	1895
2020 Q1	$121K	Buy	646 +133	+26%	+$31.3K	﹤0.01%	1913
2019 Q4	$124K	Hold	513	–	–	﹤0.01%	2201
2019 Q3	$87K	Buy	513 +401	+358%	+$90.8K	﹤0.01%	2370
2019 Q2	$21.9K	Buy	+112	New	+$24.2K	﹤0.01%	2595
2018 Q4	–	Sell	-305	Closed	-$190K	–	2575
2018 Q3	$190K	Buy	+305	New	+$135K	﹤0.01%	2043

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TECX Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 259 shares — an estimated $17.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TECX in Q3 2018 and held it in 11 quarters. The position peaked at $190K in Q3 2018. 93 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 259 Tectonic Therapeutic shares in Q4 2021, an estimated $17.4K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s Tectonic Therapeutic position peaked at $190K in Q3 2018.
93 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.